Frequently Asked Questions

  • SHINGRIX vaccine locator icon

    Shingles is an itchy and painful skin rash caused by reactivation of the varicella zoster virus (the same virus that causes chickenpox). SHINGRIX uses your body’s own immune cells to boost your immune system’s defenses against shingles. It is the only shingles vaccine proven to be greater than 90% effective in clinical trials.

  • 99% of adults over 50 years old are at risk for shingles

    If you’re one of the 99% of adults over 50 years old who have had chickenpox, the virus that causes shingles is inside your body and can reactivate at any time. 1 in every 3 people in the US will get shingles in their lifetime. No matter how healthy you feel, your immune system declines as you age, and that puts you at an increased risk for shingles.

  • 1 in 3 people will get shingles

    Yes, your risk for shingles increases as you get older. 1 out of 3 people in the US will get shingles.

  • Shingles is not contagious, but the virus can be spread from a person with active shingles to someone who has never had chickenpox – or was never protected against it. In this case, the person exposed to the virus might develop chickenpox. The virus spreads through direct contact with fluid from the blisters of the shingles rash. Once the shingles blisters have developed crusts, they’re no longer contagious.

  • Rx insurance information icon

    Most insurance plans cover SHINGRIX. Check with your doctor or pharmacist about vaccination.

  • SHINGRIX is greater than 90% effective icon

    SHINGRIX is the only shingles vaccine proven to be greater than 90% effective in adults 50 years and older in clinical trials.

  • 2-dose calendar icon

    SHINGRIX is given as a 2-dose series, with the second shot administered 2 to 6 months after the first shot. It’s important to receive both shots of SHINGRIX. If you’ve already had your first dose, sign up for voice, email, and text reminders for your second dose.

  • Injection-site icon

    Pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach are all common side effects of SHINGRIX. Talk to your doctor about ways to manage injection-site pain.

  • pregnancy icon

    SHINGRIX was not studied in pregnant or nursing women. Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding.

  • Since SHINGRIX has been approved, there has been an unprecedented amount of demand from patients and healthcare providers. Due to the remarkably high demand, you may find that your healthcare provider or local pharmacy is temporarily out of stock.

  • To address the current high demand, GSK has significantly increased deliveries and accelerated shipments of doses of vaccine for this year, and SHINGRIX is expected to be available throughout 2018 and shipped on a regular basis.

  • If you – as a patient – are having difficulty finding the vaccine at your regular provider’s office or pharmacy, you should ask this provider or pharmacy to contact you when it is available.

    You can also use the SHINGRIX Vaccine Locator to locate providers or pharmacies that have been offering the vaccine. It is recommended that you call locations before your visit to ensure the vaccine is available.

  • GSK has increased the distribution of SHINGRIX to help ensure patients have the opportunity to complete the 2-dose series. Please contact your healthcare provider or pharmacy if you have any questions. They can also let you know when SHINGRIX is available to them.